Filing metadata

Accession number
0000950170-24-014523
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Feb 13, 2024
Reporting period
Dec 28, 2021
Description
Insider transaction

Explore SEC Filings Hub